의료용 레이저 시장 보고서 : 유형별, 제품 유형별, 용도별, 최종 사용자별, 지역별(2024-2032년)

The global medical lasers market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.3% during 2024-2032.

Medical lasers are devices used to treat or remove tissues through precisely focused light sources. They rely on non-ionizing radiation to reduce blood loss, decrease postoperative discomfort and minimize the chances of wound infection. They aid in cancer therapy, bio-sensing, bio-imaging, drug delivery, and diagnostics of cancer cells. They also assist in cosmetic surgery to remove tattoos, scars, stretch marks, sunspots, wrinkles, birthmarks, and spider veins or hair. Apart from this, they help in tumor and cataract removal, breast surgery, plastic surgery, and other surgical procedures. As a result, they find extensive applications in hospitals, specialty clinics, and ambulatory surgical centers.

Medical Lasers Market Trends:

Due to the increasing adoption of minimally and non-invasive procedures to enhance clinical outcomes, there is a rise in the demand for medical lasers. This, along with the growing awareness among individuals about aesthetic procedures, such as acne prevention, body contouring, and dermal resurfacing, represents one of the key factors driving the market. Moreover, there is an increase in the utilization of medical lasers due to less pain, minimal incisions, and faster recovery across the globe. This, coupled with technological advancements in laser-assisted devices that support advance treatments in healthcare facilities with reduced risk of post-procedural complications, is propelling the growth of the market. Additionally, several initiatives undertaken by healthcare organizations to promote medical tourism are offering lucrative growth opportunities to industry investors. Besides this, key market players are extensively investing in research and development (R&D) activities to introduce a new low-level green laser for body fat reduction. Furthermore, the burgeoning healthcare industry is positively influencing the market. Other growth-inducing factors are the rising geriatric population, increasing prevalence of eye disorders, and the growing disposable incomes.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global medical lasers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product type, application and end user.

Breakup by Type:

Surgical

Cosmetic

Dental

Others

Breakup by Product Type:

Solid-State Laser Systems

Holmium Yttrium Aluminum Garnet Laser (Ho:Yag) Systems

Erbium Yttrium Aluminum Garnet Laser (Er:Yag) Systems

Neodymium Yttrium Aluminum Garnet Laser (Nd:Yag) Systems

Potassium Titanyl Phosphate Laser Systems

Alexandrite Laser Systems

Ruby Laser Systems

Gas Laser Systems

CO2 Laser Systems

Argon Laser Systems

Krypton Laser Systems

Metal Vapor (Copper and Gold) Laser Systems

Helium-Neon (He-Ne) Laser Systems

Excimer Laser Systems

Dye Lasers Systems

Diode Laser Systems

Breakup by Application:

Ophthalmology

Dermatology

Gynecology

Dentistry

Urology

Cardiovascular

Others

Breakup by End User:

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Artivion Inc., Bausch Health Companies Inc., BIOLASE Inc., Boston Scientific Corporation, Cutera Inc., Ellex Medical Lasers (Lumibird Medical), IRIDEX Corporation, Koninklijke Philips N.V., Lumenis Ltd., Novartis AG, PhotoMedex Inc. and Syneron Medical Ltd.

Key Questions Answered in This Report:

• How has the global medical lasers market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global medical lasers market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the product type?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global medical lasers market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Lasers Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Surgical
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Cosmetic
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Dental
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Product Type

• 7.1 Solid-State Laser Systems
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Holmium Yttrium Aluminum Garnet Laser (Ho:Yag) Systems
    • 7.1.2.2 Erbium Yttrium Aluminum Garnet Laser (Er:Yag) Systems
    • 7.1.2.3 Neodymium Yttrium Aluminum Garnet Laser (Nd:Yag) Systems
    • 7.1.2.4 Potassium Titanyl Phosphate Laser Systems
    • 7.1.2.5 Alexandrite Laser Systems
    • 7.1.2.6 Ruby Laser Systems
  • 7.1.3 Market Forecast
• 7.2 Gas Laser Systems
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 CO2 Laser Systems
    • 7.2.2.2 Argon Laser Systems
    • 7.2.2.3 Krypton Laser Systems
    • 7.2.2.4 Metal Vapor (Copper and Gold) Laser Systems
    • 7.2.2.5 Helium-Neon (He-Ne) Laser Systems
    • 7.2.2.6 Excimer Laser Systems
  • 7.2.3 Market Forecast
• 7.3 Dye Lasers Systems
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Diode Laser Systems
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Application

• 8.1 Ophthalmology
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Dermatology
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Gynecology
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Dentistry
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Urology
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Cardiovascular
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast
• 8.7 Others
  • 8.7.1 Market Trends
  • 8.7.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Specialty Clinics
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Ambulatory Surgical Centers
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Artivion Inc.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Bausch Health Companies Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 BIOLASE Inc.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Boston Scientific Corporation
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Cutera Inc.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
  • 15.3.6 Ellex Medical Lasers (Lumibird Medical)
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 IRIDEX Corporation
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
  • 15.3.8 Koninklijke Philips N.V.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Lumenis Ltd.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 SWOT Analysis
  • 15.3.10 Novartis AG
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 PhotoMedex Inc.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 Syneron Medical Ltd.
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 SWOT Analysis